Fifth Third Bancorp’s Medifast MED Stock Holding History

Fifth Third Bancorp’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$509	Buy	+48	New	+$554	﹤0.01%	4231
2024 Q3	–	Sell	-122	Closed	-$2.66K	–	2593
2024 Q2	$2.66K	Buy	122 +92	+307%	+$2.45K	﹤0.01%	2232
2024 Q1	$1.15K	Sell	30 -30	-50%	-$1.45K	﹤0.01%	2260
2023 Q4	$4.03K	Sell	60 -57	-49%	-$3.97K	﹤0.01%	2246
2023 Q3	$8.76K	Buy	117 +50	+75%	+$4.44K	﹤0.01%	2001
2023 Q2	$6.17K	Buy	67 +36	+116%	+$3.21K	﹤0.01%	2137
2023 Q1	$3.21K	Buy	31 +4	+15%	+$443	﹤0.01%	2460
2022 Q4	$3.11K	Buy	27 +7	+35%	+$815	﹤0.01%	2345
2022 Q3	$2K	Buy	20 +7	+54%	+$1K	﹤0.01%	2443
2022 Q2	$2K	Buy	+13	New	+$2.33K	﹤0.01%	2443
2022 Q1	–	Sell	-26	Closed	-$5K	–	2734
2021 Q4	$5K	Buy	26 +12	+86%	+$2.48K	﹤0.01%	2334
2021 Q3	$3K	Sell	14 -154	-92%	-$37.9K	﹤0.01%	2359
2021 Q2	$48K	Buy	+168	New	+$45.5K	﹤0.01%	1465
2016 Q1	–	Sell	-26	Closed	-$1K	–	2532
2015 Q4	$1K	Hold	26	–	–	﹤0.01%	2626
2015 Q3	$1K	Buy	26 +6	+30%	+$175	﹤0.01%	2757
2015 Q2	$1K	Hold	20	–	–	﹤0.01%	2734
2015 Q1	$1K	Buy	+20	New	+$635	﹤0.01%	2635

Other funds holding MED

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fifth Third Bancorp's MED Position: Q2 2026 in Review

Fifth Third Bancorp opened a new position in Medifast (MED) in Q2 2026: 48 shares worth $509. The stake represents ﹤0.01% of the portfolio and ranks #4231 among its holdings. This is a return to the name: Fifth Third Bancorp previously reported a position in MED as recently as Q2 2024.

Fifth Third Bancorp first reported a position in MED in Q1 2015 and has held it in 17 quarters since. The position peaked at $48K in Q2 2021. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

Fifth Third Bancorp held 48 shares of Medifast worth $509 as of Q2 2026.
Medifast was a new Fifth Third Bancorp position in Q2 2026.
Medifast made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4231 holding.
Fifth Third Bancorp first reported a position in Medifast in Q1 2015 and has held it in 17 quarters since.
Fifth Third Bancorp's Medifast position peaked at $48K in Q2 2021.
113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.